- Copaxone
- n.
* * *
Co·pax·one (ko-pakґsōn) trademark for a preparation of glatiramer acetate.
Medical dictionary. 2011.
* * *
Co·pax·one (ko-pakґsōn) trademark for a preparation of glatiramer acetate.Medical dictionary. 2011.
Copaxone® — /kō pakˈsōn/ noun A synthetic protein, simulating myelin, used in treating multiple sclerosis … Useful english dictionary
Copaxone — Wikipedia:Redaktion Chemie/ausgeblendete Strukturformel Allgemeines Freiname Glatirameracetat Andere Namen L Alanin L Glutaminsäure L Lysin L Tyrosin Polymerisat 6,0:1,9:4,7:1,0 Copolymer 1 Summenforme … Deutsch Wikipedia
Copaxone — … Википедия
Copaxone — n.; see glatiramer … The new mediacal dictionary
Glatiramer acetate — Systematic (IUPAC) name acetic acid; (2S) 2 amino 3 (4 hydroxyphenyl)propanoic acid; (2S) 2 aminopentanedioic acid; (2S) 2 aminopropanoic acid; (2S) 2,6 diaminohexanoic acid Clin … Wikipedia
Copolymer-1 — Wikipedia:Redaktion Chemie/ausgeblendete Strukturformel Allgemeines Freiname Glatirameracetat Andere Namen L Alanin L Glutaminsäure L Lysin L Tyrosin Polymerisat 6,0:1,9:4,7:1,0 Copolymer 1 Summenforme … Deutsch Wikipedia
Copolymer 1 — Wikipedia:Redaktion Chemie/ausgeblendete Strukturformel Allgemeines Freiname Glatirameracetat Andere Namen L Alanin L Glutaminsäure L Lysin L Tyrosin Polymerisat 6,0:1,9:4,7:1,0 Copolymer 1 Summenforme … Deutsch Wikipedia
Glatirameracetat — Wikipedia:Redaktion Chemie/ausgeblendete Strukturformel Allgemeines Freiname Glatirameracetat Andere Namen L Alanin L Glutaminsäure L Lysin L Tyrosin Polymerisat 6,0:1,9:4,7:1,0 Copolymer 1 … Deutsch Wikipedia
Treatment of multiple sclerosis — Several therapies for multiple sclerosis (MS) exist, although there is no known cure. Multiple sclerosis is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS). The most common initial course of the disease… … Wikipedia
Therapies under investigation for multiple sclerosis — Scientists continue their efforts to create new and better therapies for multiple sclerosis. There are a number of treatments under investigation that may improve function, curtail attacks, or limit the progression of the underlying disease. Many … Wikipedia